Items where authors include "Chmielowski, B"

Conference or Workshop Item

Milhem, MM, Vanderwalde, AM, Bowles, TL et al. (16 more authors) (2022) Updated results from the skin cancer cohorts from an ongoing phase 1/2 multicohort study of RP1, an enhanced potency oncolytic HSV, combined with nivolumab (IGNYTE). In: 2022 ASCO Annual Meeting, 03-07 Jun 2022, Chicago, Illinois.

Proceedings Paper

Harrington, K, Nenclares, P, Leslie, I et al. (21 more authors) (2022) 610 Immune biomarker analysis of RP1 in combination with nivolumab in patients with advanced solid tumors. In: Journal for ImmunoTherapy of Cancer. SITC 37th Annual Meeting (SITC 2022), 08-12 Nov 2022, Boston, USA. BMJ , A642.

Milhem, M, VanderWalde, A, Bowles, T et al. (20 more authors) (2022) 611 Biodistribution and shedding analysis following treatment with RP1 oncolytic immunotherapy in the skin cancer patients from the IGNYTE clinical trial. In: Journal for ImmunoTherapy of Cancer. SITC 37th Annual Meeting (SITC 2022), 08-12 Nov 2022, Boston, USA. BMJ , A643-A643.